| Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which Amoxicillin MICs differ | M. García et al./ Antimicrob. Agents. Chemother. 2005; 49:996-1001 |
| Effect of opsonophagocytosis mediated by specificantibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhaced 2000/125 mg co-amoxiclav to healthy volunteers | L. Alou et al./ JAC 2005; 55(5): 742-747 |
| Urinary Concentrations and Bactericidal Activity Against Amoxicillin-Nonsusceptible Strains of escherichia Coli with Singel-Dose, Oral, Sustained -release Amoxicillin/Clavulanic Acid: A Phase I, Ope-Label, Noncomparative Clinical Trial in Healthy Volunteers | Dra. Ponte et al./ Clinical Therapeutic 2005; 27: 1043-1049. |
| Estudio epidemiológico para evaluar las características clínicas y terapéuticas de los pacientes diagnosticados de Esquizofrenia en España | Baca E. Proyecto ACEE 2004/ X Congreso Nacional de Psiquiatría 2006 |
| Estudio epidemiológico para evaluar las características clínicas y terapéuticas de los pacientes diagnosticados de Esquizofrenia en España | Leal C. Proyecto ACEE 2005/ X Congreso Nacional de Psiquiatría 2006 |
| Treatment satisfaction with premixed insulin aspart 30%/70% in patients with type 2 diabetes mellitus | R. Antuña et al./ Av Diabetol. 2008; 24(1): 441-446 |
| Efficacy and safety of biphasic insulin aspart 30/70 in the treatment of patients with type 2 diabetes mellitus | Duran Garcia S et al./ Endocrinol Nutr. 2008; 55(4):159-64 |
Inicio
